Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 3, 2006, Pages 475-482

  Singh, Harmeet ^a   Reed, John ^a   Noble, Sylvia ^a   Cangiano, Jose L ^a   Van Wyck, David B ^a  

^a Western Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; FERRIC ION; FERRIC OXIDE, SACCHARATED; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERYTHROPOIESIS; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL;

ANEMIA, IRON-DEFICIENCY; EPOETIN ALFA; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 33750849358     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01541005     Document Type: Article

References (0)